CP 060S

Known as: CP-060S 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2002
012319962002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Vasoinhibitory effects of (-)-(S)-2-[3,5-bis(1, 1-dimethylethyl)-4-hydroxyphenyl]-3-[3-[N-methyl-N-[2-(3, 4-methylenedioxyphenoxy… (More)
Is this relevant?
1999
1999
CP-060 S, (-)-( S)-2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-3-[3-[N-methyl-N-[2-(3 ,4-methylenedioxyphenoxy)ethyl]-amino… (More)
Is this relevant?
1999
1999
The effect of (-)-(S)-2-[3,5-bis(1, 1-dimethylethyl)-4-hydroxyphenyl]-3-[3-[N-methyl-N-[2-(3, 4-methylenedioxyphenoxy)ethyl]amino… (More)
Is this relevant?
1999
1999
1. We examined the effects of CP-060S on cardiac function and myocardial oxygen consumption (MVO2) in anesthetized dogs. 2. CP… (More)
Is this relevant?
1999
1999
CP-060S is a novel compound that can inhibit the slow inward calcium current as well as the veratridine-induced, noninactivating… (More)
Is this relevant?
1998
1998
The myocardial infarct size (IS)-limiting effect of CP-060S, a novel cardioprotective drug that prevents Na+-, Ca2+-overload and… (More)
Is this relevant?
1998
1998
CP-060S, (-)-(S)-2-[3,5-bis(1,1-dimethylethyl)-4-hydroxypheny1]-3-[3-[N-met hyl-N-[2-(3,4-methylenedioxyphenoxy)ethyl]amino… (More)
Is this relevant?
1998
1998
1. CP-060S is a novel sodium and calcium overload inhibitor, and is also characterized as a calcium channel blocker. As these… (More)
Is this relevant?
1997
1997
The newly developed cardioprotective drug, CP-060S, (-)-(S)-2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-3-[3-[N-methyl-N- [2… (More)
Is this relevant?
1996
1996
CP-060S, (-)-(S)-2-[3,5-bis(1, 1-dimethylethyl)-4-hydroxyphenyl]-3-[3-[N-methyl-N-[2-(3, 4-methylenedioxyphenoxy)ethyl]amino… (More)
Is this relevant?